the aid library

LIST OPTIONS

Filter

556

Download (180)

View PDF (300)

Risk Factors of Stroke in Western and Asian Countries: A Systematic Review and Meta-analysis of Prospective Cohort Studies

X. Chen; L. Zhou; Y. Zhang; et al. BioMed Central (2014) CC

Chen et al. BMC Public Health 2014, 14:776 http://www.biomedcentral.com/1471-2458/14/776

Download (114)

View PDF (150)

Myocarditis and pericarditis after mRNA COVID-19 vaccination in children: Interim guidance

SickKids (2020) CC

Download (2577)

View PDF (1019)

List of Registered Medical Device for Import

Directorate General of Drug Administration,, Ministry of Health and Family Welfare, People's Republic of Bangladesh (2017) C1

Download (407)

View PDF (370)

Religion, Women’s Health and Rights: Points of Contention and Paths of Opportunities

United Nations Population Fund (2016) C1

Download (639)

View PDF (856)

Inclusion of People with Disabilities in Cambodia

Emanuela Pozzan (2009) CC

Download (312)

View PDF (499)

Partnerships, Advocacy and Communication for Social Change. Webinar 7. Companion Technical Booklet

Cable, C. UNICEF (2014)

Download (182)

View PDF (250)

COVID-19 Scientific and Public Health Policy Update – (6 July 2022)

African Union; Africa CDC Centres for Disease Control and Prevention (2022) C1

This bi-weekly brief details the latest developments in scientific knowledge and public health policy from around the world as well as updates to the COVID-19-related guidance from Africa CDC, WHO and other public health agencies.

Download (311)

View PDF (272)

Safety evaluation of certain contaminants in food: prepared by the ninety-first meeting of the Joint FAO/WHO Expert Committee on Food Additives (‎JECFA)‎

World Health Organisation (WHO) (2023) C_WHO

This volume contains monographs prepared at the ninety-first meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), which met virtually online from 1 to 12 February 2021. The detailed monographs in this volume summarize data on specific contaminants in food. Individual monographs ... more

Download (345)

View PDF (456)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (356)

View PDF (528)

Persistent Global Acute Malnutrition

Young, H., Marshak, A. Feinstein International Center (2017) C3

A discussion paper on the scope of the problem, its drivers, and strategies for moving forward for policy, practice, and research In many protracted emergencies, the prevalence rates of global acute malnutrition (GAM) regularly exceed the emergency threshold of > 15% of children with acute malnutri... more

Download (270)

View PDF (311)

Toolkit for safe listening devices

World Health Organization WHO (2019) C_WHO

Download (98)

View PDF (102)

Global report on diabetes World Health Organization 2016

World Health Organization WHO (2016) C_WHO

Diabetes is a serious, chronic disease that occurs either when the pancreas does not produce enough insulin (a hormone that regulates blood sugar, or glucose), or when the body cannot effectively use the insulin it produces. Diabetes is an important public health problem, one of four priority noncom... more

Download (176)

View PDF (232)

WHO guidelines on hand hygiene in health care: a summary

World Health Organization WHO (2009) C_WHO

Confronted with the important issue of patient safety, in 2002 the Fifty-fifth World Health Assembly adopted a resolution urging countries to pay the closest possible attention to the problem and to strengthen safety and monitoring systems. In May 2004, the Fifty-seventh World Health Assembly approv... more

Download (142)

View PDF (141)

Prevalence and factors associated with prediabetes and diabetes mellitus in Kenya: results from a national survey

Mohamed, S.F.; Mwangi M., Mutua1 M.K., et al. BMC Public Health (2018) C1

Mohamed et al. BMC Public Health 2018, 18(Suppl 3):1215 https://doi.org/10.1186/s12889-018-6053-xpre-

Download (1482)

View PDF (2478)

Screening for Type 2 Diabetes

WHO WHO (2003)

Report of a World Health Organization and International Diabetes Federation meeting

External Link

Infection control - Pocket reference - for students, nurses and other healthcare professionals

Clinical Pocket Reference (2020) CC

Infection control is the forth edition from Clinical Pocket Reference for Nurses.

Download (211)

View PDF (179)

Impact on Essential Health Services

The Independent Panel (2021) CC

Background paper 8 The Independent Panel for Pandemic Preparedness and Response May 2021

Download (194)

View PDF (181)

Integrating psychosocial interventions and support into HIV services for adolescents and young adults

World Health Organisation (WHO) (2023) C_WHO

Adolescence, defined as the period between 10 and 19 years of age, is a developmental stage during which many psychosocial and mental health challenges emerge. There is a well-established link between mental health and HIV outcomes. Adolescents and young adults living with HIV typically have additio... more

Download (286)

View PDF (717)

Four Decades of Cross-Mediterranean Undocumented Migration to Europe

International Organization for Migration IOM (2017) C1

External Link

The Impacts of Dietary Change on Greenhouse Gas Emissions, Land Use, Water Use, and Health: A Systematic Review

Aleksandrowicz L., Green R., Joy E., et al. (2016) CC

PlosOne https://doi.org/10.1371/journal.pone.0165797; Food production is a major driver of greenhouse gas (GHG) emissions, water and land use, and dietary risk factors are contributors to non-communicable diseases. Shifts in dietary patterns can therefore potentially provide benefits for both the en... more